Sage Therapeutics drug for rare condition deemed a failure, but company may see a path forward
September 12, 2017 at 12:26 PM EDT
Causes of the condition could affect how well the treatment works, the company’s CEO tells MarketWatch.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|